Investors

Event Details

EDELWEISS Phase 2b clinical trial results of linzagolix (OBE2109) for the treatment of endometriosis related pain

Monday, June 18, 2018 8:00 a.m. ET  

Webcast Presentation

Title
EDELWEISS Phase 2b clinical trial results of linzagolix (OBE2109) for the treatment of endometriosis related pain
Date / Time
18 Jun 2018 8:00 a.m. ET